A Spanish family from Madrid was in Montreal in July visiting Dr. Bernard Brais and his research laboratory. Their son has being diagnosed with ARSACS.
Dr. Brais is a key member of the ARSACS research team.
The great initiative of the Baratta brothers, students at Selwyn House School, raised $ 1,000 for research on ARSACS via the sale of the book “375 Mtl-joke booklet”.
Many thanks to the young students for their initiative and to all those who encouraged them.
The Foundation has received 17 applications for research fellowship for the 2017-2018 year. The Foundation would like to thank all the applicants for their interest in ARSACS research. The Scientific Committee would evaluate each of the applications and a final decision concerning which research projetcs will obtain financing in 2017-2018 will be announced in July 2017.
On May 31st, 2 students at Selwyn House School will visit each elementary school class to tell a joke from their 375 Mtl-joke booklet. The booklet is to commemorate Montreal’s 375th anniversary and to raise funds for ARSACS. The minimum suggested contribution is $2. Get ready to roll on the floor laughing! To order the booklet, please contact Suzanne at firstname.lastname@example.org Jokes are in English.
Despite the cold and the rain, the ARSACS research team raised $2,500 on Saturday April 22 as part of the Scotiabank Charity Challenge Run . Special thanks to Alanna Watt for organizing the team and to the participants and sponsors for making this event a success. Photos of the ARSACS team
Dr.Maltecca (Italy) has started a pilot drug treatment in the Scacs KO mouse. The results should be known in few months.
The Foundation offers annual research fellowships that will lead to a treatment for ARSACS. A $100,000 grant could be awarded for a period of one year with possibility for renewal for a second year. Researchers interested should apply at the latest by May 25, 2017. Application form
ARSACS researchers will be at the Institute for Research in Immunology and Cancer at the University of Montreal (IRIC) on December 13, 2016 to analyze in greater details the first results of the drug screening therapeutic molecules carried out over the last months . Stay tuned.